Speakers
Research Presentations
In this talk, Dr. Susy Hota will discuss the emerging role of microbiome-based therapeutics in clinical practice, focusing on the importance of stewardship in their implementation. Drawing on her extensive experience as an infectious disease physician, academic leader, and co-director of the Microbiota Therapeutics Outcomes Program, Dr. Hota will explore best practices for integrating therapies like fecal microbiota transplantation into patient care. She will also highlight the need for responsible management, evidence-based approaches, and ongoing research to ensure these innovative treatments are both effective and sustainable.
Dr. Hota is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Toronto, Division Head for Infectious Diseases at University Health Network and Sinai Health and Medical Director of Infection Prevention and Control at University Health Network in Toronto, Canada. Her academic interests include management of Clostridioides difficile infection, fecal microbiota transplantation (FMT), and emergency preparedness for infectious diseases. She co-leads the Microbiota Therapeutics Outcomes Program, which supports the use of microbiome-based therapeutics for clinical care and research applications in Toronto, Ontario, Canada.